Biogen Pharmachem Industries Reports Strong Financial Results, Indicating Positive Growth Trajectory

Jul 23 2025 06:15 PM IST
share
Share Via
Biogen Pharmachem Industries has announced its financial results for the quarter ending March 2025, showcasing significant improvements. The company achieved its highest operating profit in five quarters at Rs 1.18 crore, with consistent performance reflected in profit before and after tax, as well as earnings per share.
Biogen Pharmachem Industries, a microcap player in the Non-Banking Financial Company (NBFC) sector, has recently reported its financial results for the quarter ending March 2025. The results, declared on July 23, 2025, indicate a notable shift in the company's evaluation, with a revision in its score reflecting a positive trajectory over the past three months.

The financial metrics reveal that Biogen Pharma achieved its highest operating profit in the last five quarters, reaching Rs 1.18 crore. This upward trend is mirrored in the profit before tax, which also stands at Rs 1.18 crore for the quarter, marking a significant achievement for the company. Additionally, the profit after tax has reached the same level, indicating a consistent performance across key profitability measures.

Earnings per share have also shown a positive development, with the company reporting Rs 0.02, the highest in the last five quarters. These results suggest that Biogen Pharma is experiencing a favorable phase, with improvements across various financial indicators.

For those interested in tracking the latest developments, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Biogen Pharma falling/rising?
Dec 06 2025 01:16 AM IST
share
Share Via
Why is Biogen Pharma falling/rising?
Nov 19 2025 10:32 PM IST
share
Share Via